Early improvement in pain predicts pain response at endpoint in patients with fibromyalgia

Journal of Pain

Volumn 12, Issue 10, 2011, Pages 1088-1094

  Wang, Fujun ^a   Ruberg, Stephen J ^a   Gaynor, Paula J ^b   Heinloth, Alexandra N ^c   Arnold, Lesley M ^d  

^a ELI LILLY AND COMPANY   (United States)

^b Indiana Biosciences Research Institute   (United States)

^c i3 Statprobe   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

duloxetine; Fibromyalgia; pain; prediction; response

Indexed keywords

DULOXETINE; PLACEBO;

ADULT; ARTICLE; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; THIOPHENES; TIME FACTORS;

EID: 80053561969     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2011.05.002     Document Type: Article

References (17)

1. L.M. Arnold, and D.J. Clauw Fibromyalgia syndrome: Practical strategies for improving diagnosis and patient outcomes Am J Med 123 2010 S2
2. L.M. Arnold, D.J. Clauw, M.M. Wohlreich, F. Wang, J. Ahl, P.J. Gaynor, and A.S. Chappell Efficacy of duloxetine in patients with fibromyalgia: Pooled analysis of 4 placebo-controlled clinical trials Prim Care Companion J Clin Psychiatry 11 2009 237 244
3. L.M. Arnold, Y. Lu, L.J. Crofford, M. Wohlreich, M.J. Detke, S. Iyengar, and D.J. Goldstein A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder Arthritis Rheum 50 2004 2974 2984 (Pubitemid 39209537)
4. L.M. Arnold, A. Rosen, Y.L. Pritchett, D.N. D'Souza, D.J. Goldstein, S. Iyengar, and J.F. Wernicke A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder Pain 119 2005 5 15 (Pubitemid 41752960)
5. L. Breiman, J. Friedman, R. Olshen, and C. Stone Classification and regression trees 1984 Chapman and Hall New York (NY)
6. A.S. Chappell, L.A. Bradley, C. Wiltse, M.J. Detke, D.N. D'Souza, and M. Spaeth A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia Int J Gen Med 1 2009 91 102
7. D.J. Clauw, and L.J. Crofford Chronic widespread pain and fibromyalgia: What we know, and what we need to know Best Pract Res Clin Rheumatol 17 2003 685 701
8. C.S. Cleeland, and K.M. Ryan Pain assessment: Global use of the Brief Pain Inventory Ann Acad Med Singapore 23 1994 129 138
9. Cymbalta [package insert]. 2010. Indianapolis (IN), Eli Lilly and Company.
10. J.T. Farrar, J.P. Young Jr., L. LaMoreaux, J.L. Werth, and R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 2001 149 158 (Pubitemid 33016608)
11. M.M. Katz, A.L. Meyers, A. Prakash, P.J. Gaynor, and J.P. Houston Early symptom change prediction of remission in depression treatment Psychopharmacol Bull 42 2009 94 107
12. B.J. Kinon, L. Chen, H. Ascher-Svanum, V.L. Stauffer, S. Kollack-Walker, J.L. Sniadecki, and J.M. Kane Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia Schizophr Res 102 2008 230 240
13. R.C. Lawrence, D.T. Felson, C.G. Helmick, L.M. Arnold, H. Choi, R.A. Deyo, S. Gabriel, R. Hirsch, M.C. Hochberg, G.G. Hunder, J.M. Jordan, J.N. Katz, H.M. Kremers, and F. Wolfe Estimates of the prevalence of arthritis and other rheumatic conditions in the United States Part II. Arthritis Rheum 58 2008 26 35
14. I.J. Russell, P.J. Mease, T.R. Smith, D.K. Kajdasz, M.M. Wohlreich, M.J. Detke, D.J. Walker, A.S. Chappell, and L.M. Arnold Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial Pain 136 2008 432 444
15. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, E. Weiller, T. Hergueta, R. Baker, and G.C. Dunbar The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 Suppl 20 1998 22 33 (Pubitemid 29001829)
16. A.G. Wade, T.E. Schlaepfer, H.F. Andersen, and C.D. Kilts Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD) J Psychiatr Res 43 2009 568 575
17. F. Wolfe, H.A. Smythe, M.B. Yunus, R.M. Bennett, C. Bombardier, D.L. Goldenberg, P. Tugwell, S.M. Campbell, M. Abeles, and P. Clark The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee Arthritis Rheum 33 1990 160 172 (Pubitemid 20098653)